Physician profile
Sayeema Daudi
NPI 1174731046
$2,380.30
in general payments reported to CMS, 2019-2025
24 companies · $145 in 2025
The $145 reported for 2025 was less than what a typical Gynecologic Oncology provider received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $532 · 2020: $165 · 2023: $283 · 2024: $1,256 · 2025: $145.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $947 · Food and Beverage: $652 · Education: $84.05.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $947.26 |
| Food and Beverage | $652.49 |
| Education | $84.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $1,083.20 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $234.94 | 2019-2025 | Lynparza |
| Astellas Pharma US INC | $149.51 | 2019-2023 | Veozah |
| Abbvie INC. | $125.00 | 2024 | |
| Avanos Medical | $114.85 | 2019 | |
| Glaxosmithkline, LLC. | $81.20 | 2023 | Jemperli |
| Amgen INC. | $62.52 | 2019-2020 | |
| Ethicon US, LLC | $60.80 | 2025 | Harmonic, Enseal |
| Innovation Technologies INC | $54.29 | 2023 | Irrisept |
| Genzyme Corporation | $52.15 | 2019-2020 | |
| Lilly USA, LLC | $49.32 | 2019 | |
| Hologic Sales and Service, LLC | $47.72 | 2024 | Fluent Fluid Management System |
| Novartis Pharmaceuticals Corporation | $38.91 | 2019-2020 | |
| Blueprint Medicines Corporation | $32.38 | 2020 | |
| Jazz Pharmaceuticals INC. | $23.74 | 2020 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celgene Corporation | $22.84 | 2019 | |
| Gilead Sciences, INC. | $22.54 | 2023 | Trodelvy |
| Bayer Healthcare Pharmaceuticals INC. | $19.68 | 2019 | |
| Seagen INC. | $18.97 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.68 | 2019 | |
| Tesaro, INC. | $18.58 | 2019 | |
| Merck Sharp & Dohme LLC | $17.65 | 2019 | |
| Janssen Biotech, INC. | $16.76 | 2020 | |
| Genentech USA, INC. | $14.07 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sayeema Daudi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.